ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.49%
S&P ASX All Technology
3,102.60
0.47%
Brent Oil
79.435
-0.56%
US Dollar vs AUD
1.51844
1.27%
Bitcoin
69,021.52
-2.46%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX
  6. Brumby Res Fpo (BMY)

  7. Brumby Res Fpo (BMY) News

BMY

Brumby Resources (BMY)

Brumby Res Fpo
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:BMY
DateTimeSourceHeadlineSymbolCompany
17/10/200907:56Dow Jones NewsUPDATE: Bristol-Myers Cuts Abilify Sales Force By About 25%ASX:BMYBristol-Myers Squibb Co.
17/10/200900:29Dow Jones NewsBristol-Myers Reduces Abilify Sales Force By About 25%ASX:BMYBristol-Myers Squibb Co.
06/10/200902:04Dow Jones NewsEU OKs AstraZeneca, Bristol Diabetes Drug For MarketingASX:BMYBristol-Myers Squibb Co.
06/10/200901:23Dow Jones NewsAstraZeneca: Onglyza EU Marketing AuthorisationASX:BMYBristol-Myers Squibb Co.
02/10/200919:45Dow Jones NewsAstraZeneca Reports Phase III Success For DapagliflozinASX:BMYBristol-Myers Squibb Co.
02/10/200906:48Dow Jones NewsDiabetes Drug From Astra, Bristol Shows Benefit In StudyASX:BMYBristol-Myers Squibb Co.
30/09/200906:14Dow Jones NewsUPDATE: Danone Denies Speculation Regarding Mead JohnsonASX:BMYBristol-Myers Squibb Co.
24/09/200900:22Dow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesASX:BMYBristol-Myers Squibb Co.
23/09/200923:22Dow Jones NewsErbitux Succeeds In One Trial, Disappoints In AnotherASX:BMYBristol-Myers Squibb Co.
23/09/200919:59Dow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerASX:BMYBristol-Myers Squibb Co.
22/09/200904:52Dow Jones NewsUPDATE:Lilly Drug Launch Seen Sluggish But CFO Sees ProgressASX:BMYBristol-Myers Squibb Co.
22/09/200904:28Dow Jones NewsLilly Drug Launch Seen Sluggish But CFO Says Progress MadeASX:BMYBristol-Myers Squibb Co.
17/09/200923:31Dow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixASX:BMYBristol-Myers Squibb Co.
16/09/200914:29Dow Jones NewsUPDATE:Taisho To Buy Bristol-Myers Asian OTC Assets For $310 MillionASX:BMYBristol-Myers Squibb Co.
16/09/200913:00Dow Jones NewsTaisho Pharma: To Acquire Bristol-Myers OTC Rights In AsiaASX:BMYBristol-Myers Squibb Co.
09/09/200907:11Dow Jones News3rd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillASX:BMYBristol-Myers Squibb Co.
09/09/200903:08Dow Jones News2nd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillASX:BMYBristol-Myers Squibb Co.
09/09/200901:40Dow Jones NewsUPDATE: Facet Again Shuns Biogen Offer, Adopts Poison PillASX:BMYBristol-Myers Squibb Co.
31/08/200920:30Dow Jones NewsStudy: Popular Heartburn Drugs Don't Interfere With PlavixASX:BMYBristol-Myers Squibb Co.
30/08/200916:30Dow Jones NewsHigh-Dose Plavix Misses Goal But Helps Some In StudyASX:BMYBristol-Myers Squibb Co.
29/08/200904:59Dow Jones NewsUS EQUITIES WEEK AHEAD: Aug Jobs Data, Auto, Retail Sales DueASX:BMYBristol-Myers Squibb Co.
29/08/200901:46Dow Jones NewsUPDATE: Boehringer's Blood-Thinner May Edge Out Bayer'sASX:BMYBristol-Myers Squibb Co.
28/08/200920:57Dow Jones NewsBoehringer Ingelheim's Blood-Thinner May Edge Out Bayer'sASX:BMYBristol-Myers Squibb Co.
26/08/200907:12Dow Jones NewsUPDATE: Study: Plavix Less Effective In Certain PatientsASX:BMYBristol-Myers Squibb Co.
26/08/200906:30Dow Jones NewsJAMA Study Shows Plavix Ineffective In Certain PatientsASX:BMYBristol-Myers Squibb Co.
21/08/200907:42Dow Jones NewsBristol-Myers Squibb Extends Medarex Tender Offer DeadlineASX:BMYBristol-Myers Squibb Co.
19/08/200909:53Dow Jones NewsPreliminary Approval Given To Bristol-Myers Holder PactsASX:BMYBristol-Myers Squibb Co.
19/08/200906:51Dow Jones News2nd UPDATE: US Patent Office Orders Re-Exam Of Plavix PatentASX:BMYBristol-Myers Squibb Co.
19/08/200903:06Dow Jones NewsUPDATE: US Patent Office Orders Re-Exam Of Plavix PatentASX:BMYBristol-Myers Squibb Co.
19/08/200901:41Dow Jones NewsUS Patent Office Orders Re-Examination Of Plavix PatentASX:BMYBristol-Myers Squibb Co.
 Showing the most relevant articles for your search:ASX:BMY

Your Recent History

FX
AUDUSD
AUD vs US Dollar
ASX
SUN
Suncorp
NASDAQ
MSFT
Microsoft
NYSE
VZ
Verizon Communications
ASX
ANZ
Australia And New Zealan...
COIN
ETHUSD
Ethereum
ASX
WBC
Westpac Banking
ASX
NAB
National Australia Bank
ASX
XJO
S&P ASX 200
NYSE
JPM
JP Morgan Chase
ASX
QBE
QBE Insurance
FX
AUDJPY
AUD vs Yen
NASDAQ
AMZN
Amazon.com
ASX
AMP
AMP
ASX
WPL
Woodside Petroleum
ASX
WOW
Woolworths
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved